Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease
- PMID: 11559692
- PMCID: PMC1729950
- DOI: 10.1136/heart.86.4.457a
Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease
Figures

Similar articles
-
The effect of angiotensin-converting enzyme inhibitors on plasma adipokine levels in normotensive patients with coronary artery disease.Endokrynol Pol. 2010 May-Jun;61(3):280-7. Endokrynol Pol. 2010. PMID: 20602303
-
[Perspectives for enalapril in the therapy of coronary heart disease. European Cardiology Symposium, Montreux, February 1997].Dtsch Med Wochenschr. 1997;122(21 Suppl Perspektiv):1-8. Dtsch Med Wochenschr. 1997. PMID: 9439478 German. No abstract available.
-
Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.Clin Ther. 2009 Oct;31(10):2113-25. doi: 10.1016/j.clinthera.2009.10.010. Clin Ther. 2009. PMID: 19922882 Clinical Trial.
-
Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function.J Am Coll Cardiol. 1996 Apr;27(5):1048-52. doi: 10.1016/0735-1097(95)00605-2. J Am Coll Cardiol. 1996. PMID: 8609320 Review.
-
Medical management of heart failure secondary to coronary artery disease.Coron Artery Dis. 1998;9(10):659-74. Coron Artery Dis. 1998. PMID: 9894618 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources